MUSBX
Price
$33.65
Change
+$0.39 (+1.17%)
Updated
Dec 20 closing price
VFINX
Price
$548.83
Change
+$5.93 (+1.09%)
Updated
Dec 20 closing price
Ad is loading...

MUSBX vs VFINX

Header iconMUSBX vs VFINX Comparison
Open Charts MUSBX vs VFINXBanner chart's image
MFS Blended Research Core Equity B
Price$33.65
Change+$0.39 (+1.17%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$548.83
Change+$5.93 (+1.09%)
VolumeN/A
CapitalizationN/A
MUSBX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MUSBX vs. VFINX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MUSBX is a Buy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. MUSBX (1.48B). VFINX pays higher dividends than MUSBX: VFINX (1.24) vs MUSBX (0.00). MUSBX was incepted earlier than VFINX: MUSBX (27 years) vs VFINX (48 years). MUSBX is a more actively managed with annual turnover of: 48.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than MUSBX: VFINX (0) vs MUSBX (1000). VFINX annual gain was more profitable for investors over the last year : 25.40 vs. MUSBX (13.99). VFINX return over 5 years is better than : 84.83 vs. MUSBX (26.69).
MUSBXVFINXMUSBX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years48 years-
Gain YTD13.52924.76355%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B1.37T0%
Annual Yield % from dividends0.001.24-
Returns for 1 year13.9925.4055%
Returns for 3 years10.2628.0437%
Returns for 5 years26.6984.8331%
Returns for 10 years54.04186.1929%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HGV39.300.65
+1.68%
Hilton Grand Vacations
ORN7.680.05
+0.66%
Orion Group Holdings
CASH73.62-0.46
-0.62%
Pathward Financial
TTD125.01-1.22
-0.97%
Trade Desk (The)
GRCE3.82-0.24
-5.91%
Grace Therapeutics Inc